The Taiwan Food and Drug Administration (TFDA) on Tuesday announced a recall of over 1.78 million tablets of an antipsychotic medication due to cross-contamination from another pharmaceutical ingredient during the manufacturing process.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares close down 1.17%
11/26/2024 01:56 PM - Business
Equipment installation begins at TSMC's 2nm Kaohsiung fab
11/26/2024 12:05 PM - Society
Jade Mountain records freezing temperatures early Tuesday
11/26/2024 11:10 AM - Business
U.S. dollar lower in Taipei trading
11/26/2024 10:34 AM - Society
Taiwan headline news
11/26/2024 10:10 AM